Good morning. Welcome to this fireside chat with Insmed. I'm Joe Schwartz from the biopharma equity research team at Leerink Partners, and it's my great pleasure to be joined by Sara Bonstein, CFO.

Researchers have introduced a new framework designed to evaluate AI systems using measurable risk and assurance metrics before deployment. The study, “Risk-Based AI Assurance Framework (RBAAF)”, ...

In crypto, the hardest part isn’t finding volatility; it’s turning volatility into a repeatable plan. Many traders either hold spot and hope for direction or overtrade and bleed fees and emotions. A ...

Peripheral artery disease (PAD) and its severe form, chronic limb-threatening ischemia (CLTI), significantly impair blood flow to the lower extremities, affecting millions of adults globally.